- Business Wire•8 months ago
Arbor Pharmaceuticals, LLC and XenoPort, Inc. today announced the successful completion of Arbor’s tender offer to purchase all issued and outstanding shares of XenoPort’s common stock for $7.03 per share in cash.
- Moody's•8 months ago
New York, June 21, 2016-- Moody's Investors Service assigned a B1 Corporate Family Rating and B1-PD Probability of Default Rating to Arbor Pharmaceuticals, LLC. Moody's also assigned a B1 rating to the ...
- PR Newswire•8 months agoLifshitz & Miller Law Firm Announces Investigation of Exterran Corporation, inContact, Inc., LinkedIn Corporation, Mines Management, Inc., Rose Rock Midstream, L.P., STAAR Surgical Company, XenoPort, Inc. and Your Community Bankshares, Inc.
NEW YORK, June 20, 2016 /PRNewswire/ -- Exterran Corporation (EXTN) Lifshitz & Miller announces investigation on behalf of Exterran investors. Specifically, on April 26, 2016, Exterran announced it will ...
XNPT : Summary for XenoPort, Inc. - Yahoo Finance
|Bid||N/A x N/A|
|Ask||N/A x N/A|
|Day's Range||N/A - N/A|
|52 Week Range||undefined - undefined|
Trade prices are not sourced from all markets
|PE Ratio (TTM)||N/A|
|Dividend & Yield||N/A (N/A)|
|1y Target Est||N/A|